Works matching DE "SUNITINIB"

Results: 289

基于美国 FAERS 数据库的舒尼替尼相关动脉血栓栓塞不良事件信号挖掘和&#39118...

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2025, v. 25, n. 7, p. 876, doi. 10.14009/j.issn.1672-2124.2025.07.023

By:

唐宗伟;
宋海驰;
李汶睿;
汪潇潇;
陈万一

Publication type:

Article

Novel magnetic carboxymethylcellulose/chitosan bio‐nanocomposites for smart co‐delivery of sunitinib malate anticancer compound and saffron extract.

Published in:

Polymer International, 2022, v. 71, n. 10, p. 1243, doi. 10.1002/pi.6408

By:

Alinavaz, Samira;
Jabbari, Parinaz;
Mahdavinia, GholamReza;
Jafari, Hessam;
Sharifi, Sina;
Lighvan, Zohreh Mehri;
Akbari, Ali

Publication type:

Article

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

Published in:

World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05252-2

By:

Fujita, Kazutoshi;
Matsushita, Yuto;
Toyoda, Shingo;
Kojima, Takahiro;
Yamashita, Shimpei;
Taniguchi, Hisanori;
Monji, Keisuke;
Ishiyama, Ryo;
Tatarano, Shuichi;
Masui, Kimihiko;
Nakamura, Eijiro;
Kaneko, Tomoyuki;
Kitano, Goshi;
Motoshima, Takanobu;
Shiraishi;
Kira, Satoru;
Murashima, Takaya;
Hara, Hiroaki;
Matsumura;
Nishiyama, Naotaka

Publication type:

Article

Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis.

Published in:

World Journal of Urology, 2023, v. 41, n. 6, p. 1563, doi. 10.1007/s00345-023-04407-x

By:

Tan, An-ju;
Mo, Dun-chang;
Wu, Ka;
Pan, Hong-mei;
Wang, Dong-mei;
Xu, Xing-xin;
Chen, Min-hong;
Pan, Shu-ying;
Li, Rou;
lian, Wen-jiao;
Wei, Meng-han

Publication type:

Article

Multi-center validation of an immune-related lncRNA signature for predicting survival and immune status of patients with renal cell carcinoma: an integrating machine learning-derived study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 12115, doi. 10.1007/s00432-023-05107-0

By:

Liu, Long;
Feng, Yi;
Guo, Chunguang;
Weng, Siyuan;
Xu, Hui;
Xing, Zhe;
Zhang, Yuyuan;
Wang, Libo;
Han, Xinwei

Publication type:

Article

N6-methyladenosine long non-coding RNAs reveal novel tool to implicate overall survival and immune microenvironment in renal clear cell carcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4675, doi. 10.1007/s00432-022-04389-0

By:

Liu, Jingchao;
Wang, Jinfu;
Zhang, Lanxin;
Wang, Jiawen;
Lv, Zhengtong;
Zhang, Yaoguang;
Wang, Jianye

Publication type:

Article

The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4411, doi. 10.1007/s00432-022-04352-z

By:

Franzese, Ciro;
Marini, Beatrice;
Baldaccini, Davide;
Badalamenti, Marco;
Navarria, Pierina;
Bellu, Luisa;
Franceschini, Davide;
Comito, Tiziana;
Clerici, Elena;
Teriaca, Maria Ausilia;
Massaro, Maria;
Di Cristina, Luciana;
Lo Faro, Lorenzo;
Tomatis, Stefano;
Scorsetti, Marta

Publication type:

Article

Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 1, p. 231, doi. 10.1007/s00432-022-04482-4

By:

Tang, Qilin;
Pan, Deshen;
Xu, Chaoliang;
Chen, Lei

Publication type:

Article

Green Analytical Chemistry Compliant UV-Visible Spectrophotometry Estimations for Sunitinib Malate.

Published in:

Journal of Applied Spectroscopy, 2025, v. 92, n. 2, p. 446, doi. 10.1007/s10812-025-01930-0

By:

Patil, Gaurav G.;
Bhave, Rucha S.;
Bobade, Preeti S.;
Telange, Darshan R.;
Ganorkar, Saurabh B.;
Shirkedkar, Atul. A.

Publication type:

Article

Hsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01580-2

By:

Tian, Xiaorui;
Liu, Jun;
Yi, Cheng;
You, Xiangyun;
Yuan, Chunli

Publication type:

Article

Molecular characterization, clinical value, and cancer–immune interactions of genes related to disulfidptosis and ferroptosis in colorectal cancer.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01031-y

By:

Liu, Xianqiang;
Li, Dingchang;
Gao, Wenxing;
Chen, Peng;
Liu, Hao;
Zhao, Yingjie;
Zhao, Wen;
Dong, Guanglong

Publication type:

Article

Sunitinib in Patients with Metastatic Renal Cell Carcinoma with Favorable Risk: Be Aware of PD-L1 Expression.

Published in:

Medical Sciences, 2024, v. 12, n. 3, p. 48, doi. 10.3390/medsci12030048

By:

Tsimafeyeu, Ilya

Publication type:

Article

NETWORK TOXICOLOGY FOR THE CARDIOVASCULAR TOXICITY ANALYSIS OF TYROSINE KINASE INHIBITORS.

Published in:

Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2024, v. 48, n. 3, p. 929, doi. 10.33483/jfpau.1478733

By:

KARAKUŞ, Fuat

Publication type:

Article

Comparing Scientific Machine Learning With Population Pharmacokinetic and Classical Machine Learning Approaches for Prediction of Drug Concentrations.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 4, p. 759, doi. 10.1002/psp4.13313

By:

Valderrama, Diego;
Teplytska, Olga;
Koltermann, Luca Marie;
Trunz, Elena;
Schmulenson, Eduard;
Fritsch, Achim;
Jaehde, Ulrich;
Fröhlich, Holger

Publication type:

Article

Cardiovascular challenges in cancer patients treated with vascular endothelial growth inhibitor therapy.

Published in:

Cardiologia Croatica, 2024, v. 19, n. 11/12, p. 558, doi. 10.15836/ccar2024.558

By:

Gabrić, Ivo Darko

Publication type:

Article

Elucidation and Regulation of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma Cells from the Perspective of Glutamine Metabolism.

Published in:

Metabolites (2218-1989), 2024, v. 14, n. 3, p. 170, doi. 10.3390/metabo14030170

By:

Morozumi, Kento;
Kawasaki, Yoshihide;
Sato, Tomonori;
Maekawa, Masamitsu;
Takasaki, Shinya;
Shimada, Shuichi;
Sakai, Takanari;
Yamashita, Shinichi;
Mano, Nariyasu;
Ito, Akihiro

Publication type:

Article

Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 9, p. 852, doi. 10.3390/metabo12090852

By:

Maillard, Maud;
Arellano, Cécile;
Vachoux, Christelle;
Chevreau, Christine;
Cabaton, Nicolas J.;
Pont, Frédéric;
Saint-Laurent, Nathalie;
Lafont, Thierry;
Chatelut, Etienne;
Thomas, Fabienne

Publication type:

Article

Secukinumab and Black Garlic Downregulate OPG/RANK/RANKL Axis and Devitalize Myocardial Interstitial Fibrosis Induced by Sunitinib in Experimental Rats.

Published in:

Life (2075-1729), 2023, v. 13, n. 2, p. 308, doi. 10.3390/life13020308

By:

Mohamad, Hoda E.;
Asker, Mervat E.;
Shaheen, Mohamed A.;
Baraka, Nourhan M.;
Fantoukh, Omer I.;
Alqahtani, Abdulaziz;
Salama, Alaa E.;
Mahmoud, Yasmin K.

Publication type:

Article

Endothelial EphrinB2 Regulates Sunitinib Therapy Response in Murine Glioma.

Published in:

Life (2075-1729), 2022, v. 12, n. 5, p. 691, doi. 10.3390/life12050691

By:

Broggini, Thomas;
Stange, Lena;
Lucia, Kristin Elizabeth;
Vajkoczy, Peter;
Czabanka, Marcus

Publication type:

Article

Investigation of M2 macrophage-related gene affecting patients prognosis and drug sensitivity in non-small cell lung cancer: Evidence from bioinformatic and experiments .

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1096449

By:

Zhen Zeng;
Jiachen Yu;
Zhuo Yang;
Kangming Du;
Yuewei Chen;
Lei Zhou

Publication type:

Article

Case report: 10-year survival of a patient with a primary hepatic gastrointestinal stromal tumor.

Published in:

2022

By:

Jie Lian;
Meiyan Feng;
Shumei Zhang;
Haibo Lu

Publication type:

Case Study

Cost-Effectiveness of Lenvatinib Plus Pembrolizumab or Everolimus as First-Line Treatment of Advanced Renal Cell Carcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.853901

By:

Wang, Ye;
Wang, Hao;
Yi, Manman;
Han, Zhou;
Li, Li

Publication type:

Article

A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.874385

By:

Jo, Hyunji;
Hong, Joohyun;
Kim, Hongsik;
Kim, Hye Ryeon;
Kwon, Ghee Young;
Kang, Kyung A.;
Park, Sung Yoon;
Kim, Chan Kyo;
Park, Byung Kwan;
Chung, Jae Hoon;
Song, Wan;
Kang, Minyong;
Sung, Hyun Hwan;
Jeon, Hwang Gyun;
Jeong, Byong Chang;
Seo, Seong Il;
Jeon, Seong Soo;
Lee, Hyun Moo;
Park, Se Hoon

Publication type:

Article

The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2α-dependent signal that drives renal cell carcinoma progression and sunitinib resistance.

Published in:

Cell & Bioscience, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13578-023-01113-4

By:

He, Hongchao;
Li, Jie;
Wang, Wei;
Cheng, Jie;
Zhou, Jian;
Li, Qunyi;
Jin, Juan;
Chen, Li

Publication type:

Article

Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors.

Published in:

Clinical & Experimental Gastroenterology, 2023, v. 16, p. 11, doi. 10.2147/CEG.S351839

By:

Thirasastr, Prapassorn;
Somaiah, Neeta

Publication type:

Article

SEC14L3 knockdown inhibited clear cell renal cell carcinoma proliferation, metastasis and sunitinib resistance through an SEC14L3/RPS3/NFκB positive feedback loop.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03206-5

By:

Jiang, Ziming;
Yang, Guangcan;
Wang, Guangchun;
Wan, Jiayi;
Zhang, Yifan;
Song, Wei;
Zhang, Houliang;
Ni, Jinliang;
Zhang, Haipeng;
Luo, Ming;
Wang, Keyi;
Peng, Bo

Publication type:

Article

Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis.

Published in:

Parasites & Vectors, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13071-023-05999-4

By:

Jiang, Huijiao;
Wang, Xiaoyi;
Guo, Lijiao;
Tan, Xiaowu;
Gui, Xianwei;
Liao, Zhenyu;
Li, Zhiwei;
Chen, Xueling;
Wu, Xiangwei

Publication type:

Article

AVAPRITINIB U ČETVRTOJ LINIJI LIJEČENJA METASTATSKOG GASTROINTESTINALNOG STROMALNOG TUMORA – PRIKAZ SLUČAJA.

Published in:

Lijecnicki Vjesnik, 2024, v. 146, p. 8, doi. 10.26800/LV-146-supl4-1

By:

Ladenhauser, Tatjana

Publication type:

Article

Comparative Neurotoxic Effects of Doxorubicin and Sunitinib: An In Vitro Study on Human Dopaminergic Neuronal Cells.

Published in:

Molecules, 2025, v. 30, n. 11, p. 2342, doi. 10.3390/molecules30112342

By:

Barbosa-Azevedo, Maria;
Igreja-Cardoso, Maria B.;
Carvalho, Félix;
Costa, Vera Marisa

Publication type:

Article

Targeted Delivery of Sunitinib by MUC-1 Aptamer-Capped Magnetic Mesoporous Silica Nanoparticles.

Published in:

Molecules, 2023, v. 28, n. 1, p. 411, doi. 10.3390/molecules28010411

By:

Torabi, Mitra;
Aghanejad, Ayuob;
Savadi, Pouria;
Barzegari, Abolfazl;
Omidi, Yadollah;
Barar, Jaleh

Publication type:

Article

Halogenated Flavonoid Derivatives Display Antiangiogenic Activity.

Published in:

Molecules, 2022, v. 27, n. 15, p. 4757, doi. 10.3390/molecules27154757

By:

Khater, Mai;
Watson, Kimberly A.;
Boateng, Samuel Y.;
Greco, Francesca;
Osborn, Helen M. I.

Publication type:

Article

KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment.

Published in:

Chemotherapy (0009-3157), 2022, v. 67, n. 2, p. 81, doi. 10.1159/000521751

By:

Napolitano, Andrea;
Thway, Khin;
Smith, Myles J.;
Huang, Paul H.;
Jones, Robin L.

Publication type:

Article

The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.

Published in:

Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae241

By:

Janssen, Jorien B E;
Brahm, Cyrillo G;
Driessen, Chantal M L;
Nuver, Janine;
Labots, Mariette;
Kouwenhoven, Mathilde C M;
Aliaga, Esther Sanchez;
Enting, Roelien H;
Groot, Jan Cees de;
Walenkamp, Annemiek M E;
Linde, Myra E van;
Verheul, Henk M W

Publication type:

Article

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1407709

By:

Xusheng Zhang;
Xiuli Ren;
Tianyu Zhu;
Wanjin Zheng;
Chengwu Shen;
Cuicui Lu

Publication type:

Article

Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1294688

By:

Yanli Wang;
Qiaohuan Deng;
Zhenyue Gao;
Guangwen Liu;
Zhengjie Su;
Yicheng Zhao;
Lixiu Zhang;
Haimiao Yang

Publication type:

Article

Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1223929

By:

Krawczyk, Kinga;
Śladowska, Katarzyna;
Holko, Przemysław;
Kawalec, Paweł

Publication type:

Article

Preparation of a Sunitinib loaded microemulsion for ocular delivery and evaluation for the treatment of corneal neovascularization in vitro and in vivo.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1157084

By:

Jieran Shi;
Jingjing Yang;
Haohang Xu;
Qing Luo;
Jun Sun;
Yali Zhang;
Zhen Liang;
Ningmin Zhao;
Junjie Zhang

Publication type:

Article

Functional Evaluation and Nephrotoxicity Assessment of Human Renal Proximal Tubule Cells on a Chip.

Published in:

Biosensors (2079-6374), 2022, v. 12, n. 9, p. 718, doi. 10.3390/bios12090718

By:

Jing, Bolin;
Yan, Lei;
Li, Jiajia;
Luo, Piaopiao;
Ai, Xiaoni;
Tu, Pengfei

Publication type:

Article

Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39981-6

By:

Zhang, Hailiang;
Bai, Lin;
Wu, Xin-Qiang;
Tian, Xi;
Feng, Jinwen;
Wu, Xiaohui;
Shi, Guo-Hai;
Pei, Xiaoru;
Lyu, Jiacheng;
Yang, Guojian;
Liu, Yang;
Xu, Wenhao;
Anwaier, Aihetaimujiang;
Zhu, Yu;
Cao, Da-Long;
Xu, Fujiang;
Wang, Yue;
Gan, Hua-Lei;
Sun, Meng-Hong;
Zhao, Jian-Yuan

Publication type:

Article

Blocking stanniocalcin 2 reduces sunitinib resistance in clear cell renal cell carcinoma.

Published in:

Neoplasma, 2022, v. 69, n. 1, p. 145, doi. 10.4149/neo_2021_210823N1206

By:

Zhen-Qian QIN;
Kong-Dong LI;
He-Zhen CHU;
Xue-Feng YUAN;
Hai-Feng SHI;
Jie GU;
Yi-Min XIE

Publication type:

Article

Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics.

Published in:

Clinical Proteomics, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12014-023-09437-6

By:

van der Wijngaart, Hanneke;
Beekhof, Robin;
Knol, Jaco C.;
Henneman, Alex A.;
de Goeij-de Haas, Richard;
Piersma, Sander R.;
Pham, Thang V.;
Jimenez, Connie R.;
Verheul, Henk M. W.;
Labots, Mariette

Publication type:

Article

Sunitinib-induced endocapillary proliferative glomerulonephritis with IgA2 deposit in addition to thrombotic microangiopathy: a case report.

Published in:

BMC Nephrology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12882-024-03732-6

By:

Zhang, Xin;
Wang, Hui;
Li, Jian;
Zhou, Fude;
Zhao, Minghui;
Su, Tao

Publication type:

Article

N<sup>6</sup>-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.

Published in:

Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01549-1

By:

Chen, Yuanlei;
Lu, Zeyi;
Qi, Chao;
Yu, Chenhao;
Li, Yang;
Huan, Wang;
Wang, Ruyue;
Luo, Wenqin;
Shen, Danyang;
Ding, Lifeng;
Ren, Liangliang;
Xie, Haiyun;
Xue, Dingwei;
Wang, Mingchao;
Ni, Kangxin;
Xia, Liqun;
Qian, Jun;
Li, Gonghui

Publication type:

Article

Hemangiopericytoma of the skull base: A long‑term complete response with trimodality treatment.

Published in:

Indian Journal of Cancer, 2024, v. 61, n. 2, p. 337, doi. 10.4103/ijc.IJC_207_21

By:

Bolukbas, Meltem K.;
Akovali, Emine S.;
Musri, Fatma Y.;
Demirtas, Rabia

Publication type:

Article

2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.

Published in:

Indian Journal of Cancer, 2023, v. 60, n. 4, p. 493, doi. 10.4103/ijc.IJC_1284_20

By:

Jaipuria, Jiten;
Jain, Ankita;
Gupta, Shashikant;
Sadasukhi, Nripesh;
Kasaraneni, Priyatham;
Singh, Amitabh;
Gupta, Kush;
Sharma, Girish;
Talwar, Vineet;
Rawal, Sudhir Kumar

Publication type:

Article

Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17883-9

By:

Fawazy, Nehmedo G.;
Panda, Siva S.;
Mostafa, Ahmed;
Kariuki, Benson M.;
Bekheit, Mohamed S.;
Moatasim, Yassmin;
Kutkat, Omnia;
Fayad, Walid;
El-Manawaty, May A.;
Soliman, Ahmed A. F.;
El-Shiekh, Riham A.;
Srour, Aladdin M.;
Barghash, Reham F.;
Girgis, Adel S.

Publication type:

Article

Receptor tyrosine kinase inhibitors negatively impact on pro-reparative characteristics of human cardiac progenitor cells.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13203-3

By:

Smith, Andrew J.;
Ruchaya, Prashant;
Walmsley, Robert;
Wright, Kathleen E.;
Lewis-McDougall, Fiona C.;
Bond, Jacquelyn;
Ellison-Hughes, Georgina M.

Publication type:

Article

miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07468-x

By:

Park, Sang Eun;
Kim, Wonju;
Hong, Ji-Ye;
Kang, Dayeon;
Park, Seulki;
Suh, Jungyo;
You, Dalsan;
Park, Yun-Yong;
Suh, Nayoung;
Hwang, Jung Jin;
Kim, Choung-Soo

Publication type:

Article

The Change of Original‐ and Generic‐Targeted Antitumor Drugs under the National Centralized Drug Procurement Policy in Hohhot: An Interrupted Time‐Series Analysis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2024, v. 2024, p. 1, doi. 10.1155/2024/6469912

By:

Wu, Rihan;
Gong, Zhaotang;
Wang, Weisong;
Zhu, Benben;
Guleng, Siri;
Raza, Faisal

Publication type:

Article

Case report: Isolated eyelid metastasis of ccRCC 5 years after receiving radical nephrectomy.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1321919

By:

Huaqi Yin;
Zheng Du;
Jiuwen Zhang;
Yongkang Ma;
Shiming Zhao;
Tiejun Yang

Publication type:

Article